杏林製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/12/09 | 1,922 | 1,922 | 1,902 | 1,917 | +32 | +1.7% | 244,000 |
2019/12/06 | 1,862 | 1,890 | 1,861 | 1,885 | +11 | +0.6% | 170,200 |
2019/12/05 | 1,871 | 1,886 | 1,864 | 1,874 | +4 | +0.2% | 139,100 |
2019/12/04 | 1,843 | 1,872 | 1,838 | 1,870 | +12 | +0.6% | 200,900 |
2019/12/03 | 1,854 | 1,865 | 1,834 | 1,858 | -21 | -1.1% | 177,800 |
2019/12/02 | 1,870 | 1,895 | 1,870 | 1,879 | +13 | +0.7% | 140,800 |
2019/11/29 | 1,887 | 1,895 | 1,865 | 1,866 | -16 | -0.9% | 157,500 |
2019/11/28 | 1,899 | 1,899 | 1,872 | 1,882 | -7 | -0.4% | 112,400 |
2019/11/27 | 1,878 | 1,897 | 1,878 | 1,889 | +12 | +0.6% | 122,400 |
2019/11/26 | 1,888 | 1,904 | 1,875 | 1,877 | +1 | +0.1% | 241,400 |
2019/11/25 | 1,884 | 1,886 | 1,864 | 1,876 | +8 | +0.4% | 101,000 |
2019/11/22 | 1,871 | 1,890 | 1,868 | 1,868 | -6 | -0.3% | 184,800 |
2019/11/21 | 1,879 | 1,897 | 1,850 | 1,874 | -3 | -0.2% | 229,600 |
2019/11/20 | 1,861 | 1,892 | 1,857 | 1,877 | +24 | +1.3% | 201,800 |
2019/11/19 | 1,824 | 1,854 | 1,822 | 1,853 | +35 | +1.9% | 244,300 |
2019/11/18 | 1,777 | 1,819 | 1,773 | 1,818 | +48 | +2.7% | 204,600 |
2019/11/15 | 1,752 | 1,784 | 1,752 | 1,770 | +8 | +0.5% | 348,600 |
2019/11/14 | 1,779 | 1,789 | 1,760 | 1,762 | -19 | -1.1% | 333,000 |
2019/11/13 | 1,812 | 1,812 | 1,781 | 1,781 | -36 | -2% | 412,500 |
2019/11/12 | 1,817 | 1,827 | 1,806 | 1,817 | -2 | -0.1% | 243,300 |
2019/11/11 | 1,816 | 1,846 | 1,801 | 1,819 | +14 | +0.8% | 377,700 |
2019/11/08 | 1,854 | 1,868 | 1,801 | 1,805 | -49 | -2.6% | 372,900 |
2019/11/07 | 1,857 | 1,867 | 1,836 | 1,854 | +3 | +0.2% | 267,700 |
2019/11/06 | 1,882 | 1,883 | 1,833 | 1,851 | -31 | -1.6% | 344,000 |
2019/11/05 | 1,865 | 1,887 | 1,856 | 1,882 | +17 | +0.9% | 219,600 |
2019/11/01 | 1,873 | 1,880 | 1,856 | 1,865 | -38 | -2% | 244,800 |
2019/10/31 | 1,897 | 1,915 | 1,881 | 1,903 | +4 | +0.2% | 229,700 |
2019/10/30 | 1,916 | 1,928 | 1,889 | 1,899 | -15 | -0.8% | 254,500 |
2019/10/29 | 1,917 | 1,925 | 1,912 | 1,914 | +17 | +0.9% | 181,000 |
2019/10/28 | 1,922 | 1,926 | 1,890 | 1,897 | -22 | -1.1% | 180,300 |
2019/10/25 | 1,920 | 1,921 | 1,902 | 1,919 | +24 | +1.3% | 243,300 |
2019/10/24 | 1,902 | 1,905 | 1,886 | 1,895 | +19 | +1% | 222,600 |
2019/10/23 | 1,856 | 1,877 | 1,838 | 1,876 | +41 | +2.2% | 234,100 |
2019/10/21 | 1,839 | 1,861 | 1,834 | 1,835 | -8 | -0.4% | 156,800 |
2019/10/18 | 1,840 | 1,852 | 1,831 | 1,843 | +18 | +1% | 179,600 |
2019/10/17 | 1,839 | 1,839 | 1,811 | 1,825 | -12 | -0.7% | 185,200 |
2019/10/16 | 1,844 | 1,855 | 1,828 | 1,837 | +27 | +1.5% | 184,300 |
2019/10/15 | 1,798 | 1,831 | 1,794 | 1,810 | +37 | +2.1% | 138,200 |
2019/10/11 | 1,767 | 1,780 | 1,759 | 1,773 | +19 | +1.1% | 103,500 |
2019/10/10 | 1,753 | 1,766 | 1,736 | 1,754 | -8 | -0.5% | 140,500 |
2019/10/09 | 1,748 | 1,770 | 1,742 | 1,762 | -4 | -0.2% | 138,600 |
2019/10/08 | 1,745 | 1,771 | 1,742 | 1,766 | +37 | +2.1% | 176,100 |
2019/10/07 | 1,740 | 1,740 | 1,719 | 1,729 | -8 | -0.5% | 100,200 |
2019/10/04 | 1,740 | 1,743 | 1,710 | 1,737 | -14 | -0.8% | 186,800 |
2019/10/03 | 1,790 | 1,790 | 1,741 | 1,751 | -78 | -4.3% | 272,800 |
2019/10/02 | 1,820 | 1,846 | 1,820 | 1,829 | +8 | +0.4% | 162,400 |
2019/10/01 | 1,789 | 1,828 | 1,789 | 1,821 | +32 | +1.8% | 203,400 |
2019/09/30 | 1,791 | 1,798 | 1,772 | 1,789 | -35 | -1.9% | 213,900 |
2019/09/27 | 1,829 | 1,837 | 1,795 | 1,824 | -43 | -2.3% | 199,400 |
2019/09/26 | 1,909 | 1,912 | 1,859 | 1,867 | -34 | -1.8% | 286,200 |
1301~
1350
件表示中 / 3674件
類似銘柄と比較する
現在ご覧いただいている「杏林製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
杏林製薬 | 139,000円 | +3.2% | +4.5% | 3.74% | 15.97倍 | 0.61倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
持田薬 | 297,200円 | +3.0% | +27.5% | 2.69% | 18.82倍 | 0.82倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
サンバイオ | 162,900円 | - | - | 0.00% | - | 75.45倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
栄研化 | 207,200円 | +0.4% | -8.4% | 2.56% | 26.60倍 | 1.50倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
ジーエヌアイ | 168,100円 | +21.7% | +999.9% | 0.00% | 6.99倍 | 2.31倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
市場注目の銘柄
チャート関連のコラム